Sign In
Buy TMCI
$3.69
+0.290 (+8.53%)
At Close: Jun 04, 2026
Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference
07:00am, Tuesday, 19'th Dec 2023
PONTE VEDRA, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts, Inc. (TMCI) Q3 2023 Earnings Call Transcript
03:42pm, Saturday, 11'th Nov 2023
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Julie Dewey - Chief Communications & Investor Relations Officer John Trea
Treace Medical Concepts Reports Third Quarter 2023 Financial Results
04:05pm, Thursday, 09'th Nov 2023
PONTE VEDRA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace to Present at Stifel 2023 Healthcare Conference
07:00am, Monday, 30'th Oct 2023
PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical Concepts Continues Growth Investments Despite High Operating Losses
12:09pm, Friday, 27'th Oct 2023
Treace Medical Concepts, Inc. sells medical device treatments for foot bunions. The global market for bunion correction systems is forecasted to reach $1.25 billion by 2030. Treace Medical's financial
Treace to Report Third Quarter 2023 Financial Results
07:00am, Monday, 16'th Oct 2023
Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET Company to Host Conference Call on Thursday, November 9, 2023 at 4:30 pm ET
Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference
04:05pm, Tuesday, 22'nd Aug 2023
PONTE VEDRA, Fla., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
Treace Medical: New Surgeons, Higher ASPs, And More Lapiplasties: A Positive Trend
01:10am, Thursday, 20'th Jul 2023
Treace Medical Concepts continues to present with attractive economic characteristics. TMCI has penetrated 5.8% of the $5bn US bunion surgery market, with management revising FY'23 revenue guidance to
Treace to Report Second Quarter 2023 Financial Results on August 8, 2023
04:15pm, Tuesday, 18'th Jul 2023
PONTE VEDRA, Fla., July 18, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace Medical Concepts, Inc. (TMCI) Q1 2023 Earnings Call Transcript
10:04pm, Monday, 08'th May 2023
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Vivian Cervantes - IR, Gilmartin Group John Treace - CEO Mark Hair - CFO Confe
Treace to Report First Quarter 2023 Financial Results on May 8, 2023
04:15pm, Thursday, 20'th Apr 2023
PONTE VEDRA, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment
Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains?
09:09am, Monday, 10'th Apr 2023
Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in th
Why Treace Medical Concepts' Shares Rose Wednesday
03:50pm, Wednesday, 08'th Mar 2023
Treace Medical focuses on medical equipment therapies to treat bunions. The company released fourth-quarter and full-year earnings after the markets closed on Tuesday.
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
04:15pm, Monday, 27'th Feb 2023
PONTE VEDRA, Fla., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment o
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
04:15pm, Tuesday, 20'th Dec 2022
PONTE VEDRA, Fla., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the
